Founders of the PSCC
CellAction Platform
Cell Therapy Acceleration
and Innovation, Cell and Gene Therapies
Discover the first technology platforms selected, accredited and financed by the PSCC.
1. Dr. Marion Alcantara;
2. Dr. Sebastian Amigorena.
+ 170
members
Offering a collaborative platform that engages partners at every stages: research, preclinical, and translational.
Bridging the gap from a scientific concept to product development.
Developing GMP-ready products.
Understanding the modes and mechanisms.
Founders of the PSCC
Unity of location on Campus Grand Parc
Pre-GMP cell & gene therapy development
• Highly qualified technical and scientific team
• Integrated clinical expertise
• Pre-GMP environment
In vitro and in vivo PoC analyses
Facilities and activities
Pre-GMP CAR-T cell engineering and manufacturing:
Technology highlights:
CliniMACS, Prodigy platform, GMP-compliant electroporators.
Analytical development:
Technology highlights:
MACSQuant cytometer / Nio(r) Digital PCR.
In vitro PoC:
Technology highlights:
Lumicks, z-Movi cell, avidity analyzer, xCELLigence RTCA, eSight Real-time live cell analyser, spectral flow cytometry platform, single-cell omics (10XGenomics), Jess automated, Western Blot (Bio-Techne).
In vivo PoC:
Technology highlights:
Xenograft and syngeneic tumor models, imaging (bioluminescence, fluorescence), stereotaxic neurosurgery, ex vivo analyses (flow cytometry, IHC, IF).
